Go to the list of all blogs
Harry Richardson's Avatar
published in Blogs
Jul 27, 2026
Why Is Inter Parfums (IPAR) Stock Up +2.34% Today?

Why Is Inter Parfums (IPAR) Stock Up +2.34% Today?

Key Takeaways

  • Inter Parfums shares rose 2.34% on Friday to close at $122.55, gaining $2.80 from the prior session's close of $119.75.
  • Primary catalyst: Canaccord Genuity raised its price target on IPAR from $123 to $141, maintaining a Buy rating — the highest target on Wall Street.
  • Secondary driver: The company's second-quarter sales update, released July 23, showed resilient demand with U.S. operations surging 18% year-over-year in Q2.
  • Broader momentum: The stock has rallied approximately 35% over the past three months, sharply outperforming the Consumer Discretionary sector and the S&P 500.
  • What's next: Investors are now focused on the company's full Q2 2026 earnings report, expected on August 4, which will provide detailed profitability metrics and updated guidance commentary.

Opening Summary

IPAR, the parent company of Inter Parfums, Inc. — a global fragrance house that designs, manufactures, and distributes prestige perfumes under licenses with brands including Coach, Montblanc, Jimmy Choo, and GUESS — climbed 2.34% in the most recent trading session. The stock finished at $122.55, up from a prior close of $119.75, extending a powerful multi-month rally that has seen shares surge roughly 35% over the past three months. The move was fueled by a bullish analyst revision and a solid preliminary second-quarter sales report that underscored the company's strengthening U.S. business.

Canaccord Genuity Lifts Price Target to Street-High $141

The most immediate spark behind the session's advance came from Canaccord Genuity. Analyst Susan Anderson raised her price target on IPAR to $141 from $123 while reaffirming a Buy rating, making it the highest target among the eight analysts covering the stock. The new target implies over 15% upside from Friday's closing level and signals confidence that Inter Parfums' brand portfolio and digital-commerce push can sustain above-market growth even as the broader fragrance category normalizes from its post-pandemic surge. The upgrade landed on July 23, giving investors a full session to digest and react to the Street's most bullish call on the name.

Q2 Sales Update Highlights U.S. Strength

Just ahead of the analyst move, Inter Parfums released preliminary second-quarter sales figures. The company reported Q2 revenue of $341 million, a 2.1% year-over-year increase, bringing first-half 2026 net sales to $686 million. While European-based operations faced headwinds — down 4% in Q2 amid soft demand in France and Germany and geopolitical disruptions in Eastern Europe and the Middle East — the U.S. business delivered an 18% surge in quarterly sales, propelled by GUESS, Donna Karan/DKNY, and Ferragamo. This bifurcated regional performance reinforced the narrative that Inter Parfums is successfully diversifying its growth levers away from a challenged European macro environment.

Digital Commerce and Brand Portfolio Momentum

Beyond the immediate catalysts, IPAR has been riding a wave of positive sentiment tied to its accelerating digital commerce strategy. The company has deepened its presence on Amazon and TikTok, where brands such as Donna Karan's Cashmere Mist deodorant continue to perform strongly. During the Q1 earnings call, management highlighted that U.S. growth hit nearly 9% in March alone and that fragrance purchases through non-traditional retailers are expanding rapidly. Separately, Inter Parfums has enriched its brand portfolio by signing long-term global fragrance licenses with David Beckham and Nautica — additions that broaden its reach in lifestyle fragrance categories and set the stage for a robust innovation pipeline heading into 2027.

Market Context and Trading Activity

Friday's move occurred against a mixed broader market backdrop. While the S&P 500 has posted modest gains year-to-date, IPAR has dramatically outperformed — up roughly 47% in 2026 — reflecting stock-specific catalysts rather than simple beta-driven movement. Trading volume of approximately 171,000 shares came in below the stock's average daily volume of roughly 289,000, suggesting the move was driven more by conviction buying from institutional investors than by broad-based speculative churn. Technically, the stock remains well above both its 50-day simple moving average of roughly $105 and its 200-day SMA near $98, with near-term resistance sitting around the 52-week high of $128.62.

What Comes Next for IPAR

The next major event for IPAR is the release of full second-quarter 2026 earnings, scheduled for August 4 after the market close. Investors will scrutinize margin performance — particularly whether the gross-margin tailwinds from direct-to-consumer channel mix and lower product-destruction costs observed in Q1 persisted into Q2. Attention will also fall on management's commentary regarding European demand stabilization, tariff mitigation efforts, and any updated full-year guidance. Risks include continued softness in key European markets, Middle East-related disruptions that could weigh on the travel-retail channel, and the potential for tariff costs to erode profitability. With the stock trading at a forward P/E above 25, execution on the 2026 plan remains critical to sustaining the rally.

Trending AI Robots

Tickeron's Trending AI Robots page showcases a curated selection of AI-powered trading bots that have demonstrated strong performance under current market conditions. With hundreds of bots spanning thousands of tickers, strategies, timeframes, and performance metrics, Tickeron surfaces only the top-performing models so traders can quickly identify actionable opportunities. Whether focused on momentum, swing trading, or longer-term trend following, these AI-driven tools offer a data-backed approach to navigating dynamic markets. Explore the Trending AI Robots page to see which strategies are leading right now.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: IPAR

Contributor

Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.


IPAR in +3.21% Uptrend, advancing for three consecutive days on August 04, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where IPAR advanced for three days, in of 342 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Aroon Indicator entered an Uptrend today. In of 266 cases where IPAR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for IPAR moved out of overbought territory on July 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on August 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IPAR as a result. In of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for IPAR turned negative on July 22, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IPAR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IPAR broke above its upper Bollinger Band on July 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.252) is normal, around the industry mean (24.451). P/E Ratio (22.096) is within average values for comparable stocks, (54.695). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.004). Dividend Yield (0.028) settles around the average of (0.034) among similar stocks. P/S Ratio (2.468) is also within normal values, averaging (2.443).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IPAR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.

Notable companies

The most notable companies in this group are Procter & Gamble Company (NYSE:PG), Colgate-Palmolive Company (NYSE:CL).

Industry description

Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.

Market Cap

The average market capitalization across the Household/Personal Care Industry is 22.75B. The market cap for tickers in the group ranges from 81.32K to 335.32B. PG holds the highest valuation in this group at 335.32B. The lowest valued company is QNTA at 81.32K.

High and low price notable news

The average weekly price growth across all stocks in the Household/Personal Care Industry was -1%. For the same Industry, the average monthly price growth was 6%, and the average quarterly price growth was -3%. DSY experienced the highest price growth at 23%, while SKIN experienced the biggest fall at -14%.

Volume

The average weekly volume growth across all stocks in the Household/Personal Care Industry was -41%. For the same stocks of the Industry, the average monthly volume growth was -42% and the average quarterly volume growth was -56%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 51
Price Growth Rating: 54
SMR Rating: 71
Profit Risk Rating: 92
Seasonality Score: -36 (-100 ... +100)
View a ticker or compare two or three
IPAR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of fragrances and fragrance related products

Industry HouseholdPersonalCare

Profile
Details
Industry
Household Or Personal Care
Address
551 Fifth Avenue
Phone
+1 212 983-2640
Employees
662
Web
https://www.interparfumsinc.com
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.